Moderna to acquire OriCiro Genomics for $85m

Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch.

Eisai and Washington University to develop neurodegenerative disease therapies

The collaboration combines Washington University’s expertise in research focused on neurodegenerative diseases with the Japan-based pharma’s experience in drug discovery and development.

Boehringer's Spevigo receives EC approval for generalised pustular psoriasis flares

The antibody, which is already approved in the US and Japan for the treatment of GPP, is also under investigation for the prevention of GPP flares and for the treatment of

Roche shares phase 3 Polivy data for previously untreated diffuse large B-cell lymphoma

The EU, Japan and most recently Canada have been among those countries which have approved Polivy in combination with R-CHP for the treatment of adult patients with previously untreated DLBCL,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]